Multi-spectral light system targets tumours:
This article was originally published in Clinica
Executive Summary
Medic Lightech has developed a multi-spectral light system for use in the photodynamic treatment of topical and internal tumours, as well as for benign lesions for treatment of skin cancer. The technique, which combines photodynamic therapy with photodynamic diagnostics, detects and treats cancer cells using a light source and drugs. The Israeli start-up firm, is targeting dermatology and cancer clinics as its primary market. The system is versatile and high-powered, the firm claims, as well as being cost-effective.
You may also be interested in...
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.